C4PAIN ApS: Financial statements 2022
CVR: 32292402
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
C4PAIN ApS (CVR 32292402) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 252,356 and a net result of DKK 237,464 compared with DKK 70,244 the year before. That is an increase of 376.6% compared with the year before. Equity in the 2022 report amounted to DKK 2,807,677. The solvency ratio was 95.9%.
- Gross Profit
- DKK 252,356
- Profit/Loss
- DKK 237,464
- Equity
- DKK 2,807,677
- Total Assets
- DKK 2,926,909
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 252 t. | 237 t. | 2.8 mio. | - |
| 2021 | - | 53 t. | 70 t. | 2.6 mio. | - |
| 2020 | - | 658 t. | 542 t. | 2.5 mio. | - |
| 2019 | - | 474 t. | 400 t. | 2 mio. | - |
| 2018 | - | 1.8 mio. | 1.4 mio. | 1.6 mio. | - |
Official annual report
Keep an eye on C4PAIN ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
C4PAIN ApS has published its annual report for 2021. Gross profit came to DKK 52,952, and the net result was DKK 70,244.
About C4PAIN ApS
C4PAIN ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Arendt-Nielsen. The company is owned by BIO-MEDICAL CONSULT HOLDING ApS. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK 159,243 and a net result of DKK 185,909 compared with DKK 1,074,600 the year before. Equity in the 2025 report amounted to DKK 4,164,765.